Mustang Bio
MBIO
36 hedge funds and large institutions have $17.9M invested in Mustang Bio in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 5 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
300% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 5
71% more funds holding
Funds holding: 21 → 36 (+15)
32% more capital invested
Capital invested by funds: $13.5M → $17.9M (+$4.39M)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.43M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.91M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.26M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$707K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$543K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$863K |
| 3 |
Goldman Sachs
New York
|
-$246K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$196K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$186K |
MBIO Hedge Fund Activity: Q2 2018 in Review
36 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2018, worth a combined $17.9M — up 32% from $13.5M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MBIO positions and 5 closed out — a net gain of 15 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, adding an estimated $6.43M. The largest seller was Millennium Management, exiting entirely with an estimated $1.1M sold.
- 36 institutional investors held Mustang Bio (MBIO) as of Q2 2018, up from 21 in Q1 2018.
- Funds reported $17.9M of Mustang Bio stock for Q2 2018, up 32% quarter-over-quarter.
- 20 funds opened new Mustang Bio positions in Q2 2018 and 5 closed out, a net change of +15 holders.
- The largest Mustang Bio buyer in Q2 2018 was BlackRock, an estimated $6.43M added.
- The largest Mustang Bio seller in Q2 2018 was Millennium Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2018.